Literature DB >> 24981050

Factors predicting nodal metastasis in endometrial cancer.

Syed Gilani1, Ian Anderson, Lamia Fathallah, Paul Mazzara.   

Abstract

PURPOSE: Evaluation of lymph node (LN) metastases in endometrial carcinoma (EC) is an important prognostic factor and a required element of cancer staging. The purpose of this study is to analyze what factors might predict the likelihood of nodal involvement in EC.
METHODS: A retrospective search of our institutional database for hysterectomies with associated LN dissection in women with EC revealed 207 cases between 2005 and 2012. Cases with primary EC, irrespective of histologic subtype, including carcinosarcomas were included in the study, but pure sarcomas were excluded. We evaluated various factors including tumor size (TS; ≤2.0 cm and >2.0 cm), depth of myometrial invasion (DMI; absent, ≤50 %, >50 %), positive pelvic cytology (PPC), cervical stromal invasion (CSI), and lymph-vascular invasion (LVI), to determine which factors correlated with the presence of LN metastasis.
RESULTS: Of the 207 (age = 62.29 ± 10.9, mean ± SD) cases of EC with LN dissection in our study group, 34 (16.42 %) had positive LNs. On univariate analysis, we found that TS (p = 0.04), tumor grade (Grade I and II versus grade III, p < 0.0001), DMI (p < 0.0001), CSI (p < 0.0001), LVI (p < 0.0001), and PPC (p = 0.001) showed statistically significant correlation with LN metastasis. However, on multivariate analysis, only DMI (p = 0.002) and LVI (p = 0.004) independently showed statistically significant correlation with LN metastasis. In addition, 18 (8.7 %) grade I and II (well/moderately differentiated) tumors with TS ≤2.0 cm and <50 % DMI showed no LN metastasis, LVI, CSI, or PPC.
CONCLUSION: We concluded that DMI and LVI were independent factors predictive of LN metastasis.

Entities:  

Mesh:

Year:  2014        PMID: 24981050     DOI: 10.1007/s00404-014-3330-5

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

1.  Association of Tumor Size With Myometrial Invasion, Lymphovascular Space Invasion, Lymph Node Metastasis, and Recurrence in Endometrial Cancer: A Meta-Analysis of 40 Studies With 53,276 Patients.

Authors:  Xiaoying Jin; Chunjuan Shen; Xiaodi Yang; Yayuan Yu; Jianzhang Wang; Xuan Che
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

2.  Risk factor analysis for massive lymphatic ascites after laparoscopic retroperitonal lymphadenectomy in gynecologic cancers and treatment using intranodal lymphangiography with glue embolization.

Authors:  Tae Wook Kong; Suk Joon Chang; Jinoo Kim; Jiheum Paek; Su Hyun Kim; Je Hwan Won; Hee Sug Ryu
Journal:  J Gynecol Oncol       Date:  2016-07       Impact factor: 4.401

3.  The sL1CAM in sera of patients with endometrial and ovarian cancers.

Authors:  Michał Wojciechowski; Ewa Głowacka; Miłosz Wilczyński; Anna Pękala-Wojciechowska; Andrzej Malinowski
Journal:  Arch Gynecol Obstet       Date:  2016-11-10       Impact factor: 2.344

4.  Sentinel-lymph-node mapping with indocyanine green in robotic-assisted laparoscopic surgery for early endometrial cancer: a retrospective analysis.

Authors:  V Cela; C Sergiampietri; M E Rosa Obino; G Bifulco; P Giovanni Artini; F Papini
Journal:  Facts Views Vis Obgyn       Date:  2020-03-27

5.  Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis.

Authors:  Emiko Yoshida; Yasuhisa Terao; Noriko Hayashi; Kaoru Mogushi; Atsushi Arakawa; Yuji Tanaka; Yosuke Ito; Hiroko Ohmiya; Yoshihide Hayashizaki; Satoru Takeda; Masayoshi Itoh; Hideya Kawaji
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.